KORU Medical Systems, Inc.

NASDAQ:KRMD

2.47 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 33.64628.51827.89623.4924.17623.16317.35415.97712.29412.24711.2458.6997.7646.3914.9213.7753.4392.3481.7351.7461.561.5281.6571.7592.0862.065
Cost of Revenue 12.31511.80912.5279.7219.248.3096.5436.5194.7244.6444.5573.3892.8192.2511.6571.2631.2430.90.6640.7290.7260.7240.961.3311.1071.126
Gross Profit 21.33216.70815.36913.7714.93614.85410.819.4587.577.6036.6885.314.9454.1393.2642.5112.1961.4481.0711.0170.8340.8050.6970.4280.9790.94
Gross Profit Ratio 0.6340.5860.5510.5860.6180.6410.6230.5920.6160.6210.5950.610.6370.6480.6630.6650.6380.6170.6170.5830.5340.5270.4210.2430.4690.455
Reseach & Development Expenses 5.2585.7424.9562.4741.2970.740.2410.0610.2370.2070.4680.2180.1480.090.0360.0280.0220.060.0420.0420.0440.0420.040.0410.0350.081
General & Administrative Expenses 00000000000000000000000000
Selling & Marketing Expenses 00000000000000000000000000
SG&A 21.63220.36620.60717.86212.0289.7728.1977.9137.7685.9434.7883.8513.5442.6561.9671.6971.3151.130.9930.9851.0670.8760.8280.6360.8281.008
Other Expenses 00.8700.6800000-0.0090000000000000000
Operating Expenses 26.8926.97826.1520.79913.74410.8528.7477.9748.3066.4225.544.3023.8822.852.0691.791.4171.2541.0931.1061.1931.050.950.8021.0811.177
Operating Income -5.558-10.27-10.781-7.03-1.2550.5861.1651.484-0.7361.1811.1471.0081.0621.2891.1950.7220.7790.194-0.022-0.088-0.359-0.246-0.253-0.374-0.102-0.237
Operating Income Ratio -0.165-0.36-0.386-0.299-0.0520.0250.0670.093-0.060.0960.1020.1160.1370.2020.2430.1910.2270.082-0.013-0.051-0.23-0.161-0.152-0.213-0.049-0.115
Total Other Income Expenses Net -0.5120.4960.1060.6650.0610.1110.0120.085-0.04-0.039-0.0730.003-0.024-0.008-0.002-0.059-0.054-0.194-0.233-0.13-0.04-0.032-0.015-0.011-0.0020.237
Income Before Tax -6.07-9.774-10.675-6.364-1.1940.6961.1771.569-0.7771.1431.0751.011.0381.2811.1930.6620.7250-0.255-0.218-0.399-0.277-0.267-0.386-0.1040.159
Income Before Tax Ratio -0.18-0.343-0.383-0.271-0.0490.030.0680.098-0.0630.0930.0960.1160.1340.20.2420.1750.2110-0.147-0.125-0.256-0.181-0.161-0.219-0.050.077
Income Tax Expense -0.0033.967-2.014-1.8020.0180.1320.2660.483-0.2420.360.3210.3070.3120.4650.489-0.227-0.3060.1960.2330.130.0010.0010.0010.0010.002-0.488
Net Income -6.067-13.741-8.661-4.563-1.2120.5640.9111.086-0.5350.7830.7530.7030.7260.8160.7040.8891.031-0.002-0.255-0.218-0.401-0.278-0.268-0.386-0.1040.25
Net Income Ratio -0.18-0.482-0.31-0.194-0.050.0240.0520.068-0.0440.0640.0670.0810.0930.1280.1430.2360.3-0.001-0.147-0.125-0.257-0.182-0.162-0.219-0.050.121
EPS -0.13-0.3-0.19-0.1-0.0290.0150.0240.029-0.0140.020.020.020.020.020.020.020.03-0-0.009-0.008-0.018-0.012-0.011-0.016-0.0050.01
EPS Diluted -0.13-0.3-0.19-0.1-0.0290.0140.0230.028-0.0140.020.020.020.020.020.020.020.03-0-0.009-0.008-0.018-0.012-0.011-0.016-0.0050.01
EBITDA -5.558-9.4-10.194-6.5661.6114.3422.3731.878-0.4741.4181.3591.2411.2531.4171.2950.7750.8560.2620.038-0.009-0.278-0.165-0.171-0.289-0.017-0.15
EBITDA Ratio -0.165-0.33-0.365-0.280.0670.1870.1370.118-0.0390.1160.1210.1430.1610.2220.2630.2050.2490.1110.022-0.005-0.178-0.108-0.103-0.165-0.008-0.072